~(131)Ⅰ标记的抗c-erbB-2单克隆抗体免疫靶向治疗卵巢癌的实验研究

来源 :中华妇产科杂志 | 被引量 : 0次 | 上传用户:madiawang
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
卵巢癌是妇科肿瘤中死亡率最高的疾病 ,由于多种客观因素的存在导致卵巢癌的治疗效果欠佳。近年来 ,出现了许多新的化疗药物 ,一定程度上提高了化疗效果 ,但卵巢癌总的 5年生存率仍然徘徊在 2 0 %~ 30 % [1] 。因此 ,探讨其他治疗方法的意义就显得尤为突出。本研究以癌基因c e Ovarian cancer is the highest mortality rate in gynecologic oncology. The treatment of ovarian cancer is poor due to many objective factors. In recent years, there have been many new chemotherapy drugs, to some extent, improved the efficacy of chemotherapy, but the overall 5-year survival rate of ovarian cancer is still hovering at 20% to 30% [1]. Therefore, to explore the significance of other treatment methods is particularly prominent. In this study, oncogene c e
其他文献